Skip to main content
Clinical Trials/EUCTR2019-002571-33-FR
EUCTR2019-002571-33-FR
Active, not recruiting
Phase 1

Transcutaneous measurement of oxygen during transient hyperoxia - SCHOTT

CHU Angers0 sites1 target enrollmentSeptember 4, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Any patient with a cardiac output measurement
Sponsor
CHU Angers
Enrollment
1
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2019
End Date
March 6, 2020
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
CHU Angers

Eligibility Criteria

Inclusion Criteria

  • \- Social security
  • \- written informed consent
  • \- cardiac output measurementscheduled within 2 hours
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 60

Exclusion Criteria

  • \- Refusal to consent
  • \- Adult patient protected under the law (guardianship)
  • \- Pregnancy or breast\-feeding women
  • \- Patients unable to understand study procedures
  • \- Subjects suffering from acute or decompensated heart or respiratory failure.

Outcomes

Primary Outcomes

Not specified

Similar Trials